These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 20332278)
1. Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies. Bolton KL; Garcia-Closas M; Pfeiffer RM; Duggan MA; Howat WJ; Hewitt SM; Yang XR; Cornelison R; Anzick SL; Meltzer P; Davis S; Lenz P; Figueroa JD; Pharoah PD; Sherman ME Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):992-9. PubMed ID: 20332278 [TBL] [Abstract][Full Text] [Related]
2. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms. Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430 [TBL] [Abstract][Full Text] [Related]
3. Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer. Bankhead P; Fernández JA; McArt DG; Boyle DP; Li G; Loughrey MB; Irwin GW; Harkin DP; James JA; McQuaid S; Salto-Tellez M; Hamilton PW Lab Invest; 2018 Jan; 98(1):15-26. PubMed ID: 29251737 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification. Allott EH; Geradts J; Sun X; Cohen SM; Zirpoli GR; Khoury T; Bshara W; Chen M; Sherman ME; Palmer JR; Ambrosone CB; Olshan AF; Troester MA Breast Cancer Res; 2016 Jun; 18(1):68. PubMed ID: 27349894 [TBL] [Abstract][Full Text] [Related]
5. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays. Laurinaviciene A; Dasevicius D; Ostapenko V; Jarmalaite S; Lazutka J; Laurinavicius A Diagn Pathol; 2011 Sep; 6():87. PubMed ID: 21943197 [TBL] [Abstract][Full Text] [Related]
6. HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays. Abrahão-Machado LF; Jácome AA; Wohnrath DR; dos Santos JS; Carneseca EC; Fregnani JH; Scapulatempo-Neto C World J Gastroenterol; 2013 Oct; 19(38):6438-46. PubMed ID: 24151362 [TBL] [Abstract][Full Text] [Related]
7. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Turbin DA; Leung S; Cheang MC; Kennecke HA; Montgomery KD; McKinney S; Treaba DO; Boyd N; Goldstein LC; Badve S; Gown AM; van de Rijn M; Nielsen TO; Gilks CB; Huntsman DG Breast Cancer Res Treat; 2008 Aug; 110(3):417-26. PubMed ID: 17912629 [TBL] [Abstract][Full Text] [Related]
8. Reliability of a computational platform as a surrogate for manually interpreted immunohistochemical markers in breast tumor tissue microarrays. Roberts MR; Baker GM; Heng YJ; Pyle ME; Astone K; Rosner BA; Collins LC; Eliassen AH; Tamimi RM Cancer Epidemiol; 2021 Oct; 74():101999. PubMed ID: 34352659 [TBL] [Abstract][Full Text] [Related]
9. AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers. Tewary S; Arun I; Ahmed R; Chatterjee S; Mukhopadhyay S J Microsc; 2021 Jan; 281(1):87-96. PubMed ID: 32803890 [TBL] [Abstract][Full Text] [Related]
10. Artificial Intelligence Algorithms to Assess Hormonal Status From Tissue Microarrays in Patients With Breast Cancer. Shamai G; Binenbaum Y; Slossberg R; Duek I; Gil Z; Kimmel R JAMA Netw Open; 2019 Jul; 2(7):e197700. PubMed ID: 31348505 [TBL] [Abstract][Full Text] [Related]
11. Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer. Krecsák L; Micsik T; Kiszler G; Krenács T; Szabó D; Jónás V; Császár G; Czuni L; Gurzó P; Ficsor L; Molnár B Diagn Pathol; 2011 Jan; 6():6. PubMed ID: 21244664 [TBL] [Abstract][Full Text] [Related]
12. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium. Howat WJ; Blows FM; Provenzano E; Brook MN; Morris L; Gazinska P; Johnson N; McDuffus LA; Miller J; Sawyer EJ; Pinder S; van Deurzen CH; Jones L; Sironen R; Visscher D; Caldas C; Daley F; Coulson P; Broeks A; Sanders J; Wesseling J; Nevanlinna H; Fagerholm R; Blomqvist C; Heikkilä P; Ali HR; Dawson SJ; Figueroa J; Lissowska J; Brinton L; Mannermaa A; Kataja V; Kosma VM; Cox A; Brock IW; Cross SS; Reed MW; Couch FJ; Olson JE; Devillee P; Mesker WE; Seyaneve CM; Hollestelle A; Benitez J; Perez JI; Menéndez P; Bolla MK; Easton DF; Schmidt MK; Pharoah PD; Sherman ME; García-Closas M J Pathol Clin Res; 2015 Jan; 1(1):18-32. PubMed ID: 27499890 [TBL] [Abstract][Full Text] [Related]
13. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience. Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364 [TBL] [Abstract][Full Text] [Related]
14. Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays. Akbar S; Jordan LB; Purdie CA; Thompson AM; McKenna SJ Br J Cancer; 2015 Sep; 113(7):1075-80. PubMed ID: 26348443 [TBL] [Abstract][Full Text] [Related]
15. Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls. Hall BH; Ianosi-Irimie M; Javidian P; Chen W; Ganesan S; Foran DJ BMC Med Imaging; 2008 Jun; 8():11. PubMed ID: 18534031 [TBL] [Abstract][Full Text] [Related]
16. Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis. Turashvili G; Leung S; Turbin D; Montgomery K; Gilks B; West R; Carrier M; Huntsman D; Aparicio S BMC Cancer; 2009 May; 9():165. PubMed ID: 19476653 [TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer. Rizzardi AE; Zhang X; Vogel RI; Kolb S; Geybels MS; Leung YK; Henriksen JC; Ho SM; Kwak J; Stanford JL; Schmechel SC Diagn Pathol; 2016 Jul; 11(1):63. PubMed ID: 27401406 [TBL] [Abstract][Full Text] [Related]
18. Astronomical algorithms for automated analysis of tissue protein expression in breast cancer. Ali HR; Irwin M; Morris L; Dawson SJ; Blows FM; Provenzano E; Mahler-Araujo B; Pharoah PD; Walton NA; Brenton JD; Caldas C Br J Cancer; 2013 Feb; 108(3):602-12. PubMed ID: 23329232 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups. Abubakar M; Orr N; Daley F; Coulson P; Ali HR; Blows F; Benitez J; Milne R; Brenner H; Stegmaier C; Mannermaa A; Chang-Claude J; Rudolph A; Sinn P; Couch FJ; Devilee P; Tollenaar RA; Seynaeve C; Figueroa J; Sherman ME; Lissowska J; Hewitt S; Eccles D; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; ; Bolla MK; Wang Q; Jones M; Schoemaker M; Wesseling J; van Leeuwen FE; Van 't Veer L; Easton D; Swerdlow AJ; Dowsett M; Pharoah PD; Schmidt MK; Garcia-Closas M Breast Cancer Res; 2016 Oct; 18(1):104. PubMed ID: 27756439 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of HER2/neu Status by Immunohistochemistry Using Computer-Based Image Analysis and Correlation With Gene Amplification by Fluorescence In Situ Hybridization Assay: A 10-Year Experience and Impact of Test Standardization on Concordance Rate. Sarode VR; Xiang QD; Christie A; Collins R; Rao R; Leitch AM; Euhus D; Haley B Arch Pathol Lab Med; 2015 Jul; 139(7):922-8. PubMed ID: 26125432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]